Trxade Group, Inc. (NASDAQ: MEDS) Continues to Report Revenue Successes Despite Pandemic’s Economic Ravages
Trxade Group provides a digitalized supply stream for pharmaceutical and health care services as part of its founding focus on empowering small, independent pharmacies that historically have struggled to compete against large corporate chains The company reported second quarter results July 27 that showed its revenues had grown 244 percent to a record $6.6 million in year-over-year quarterly results, triple the amount garnered during the first quarter of the year The global COVID-19 pandemic caught world markets by surprise during the spring, but Trxade’s emphasis on telemedicine and other online-accessible services positioned it as a visionary company well able to…